This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Woelk, H. Articles by Grünwald, J. Search for Related Content PubMed PubMed Citation Articles by Woelk, H. Articles by Grünwald, J. Social Bookmarking                         What's this?

Benefits and Risks of the Hypericum Extract LI 160: Drug Monitoring Study with 3250 Patients

G. Burkard

J. Grünwald

Effectiveness and acceptance of a 4-week treatment with hypericum extract LI 160 were investigated by 663 private practitioners. The results of the 3250 patients (76% women and 24% men), were recorded using data sheets. The age of the patients ranged from 20 to 90 years (mean 51 years). Of the patients, 49% were mildly depressed, 46% intermediate, and 3% severely depressed. In about 30% of the patients, the situation normalized or improved during the therapy. Undesired drug effects were reported in 79 (2.4%) patients and 48 (1.5%) discontinued the therapy. Most frequently noted side effects were gastrointestinal irritations (0.6%), allergic reactions (0.5%), tiredness (0.4%), and restlessness (0.3%). (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S34-S38).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S34-S38 (1994)
DOI: 10.1177/089198879400700110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Zuess An Integrative Approach to Depression: Part 2--Assessment and Treatment Complementary Health Practice Review, April 1, 2003; 8(2): 99 - 115. [Abstract] [PDF]

				Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International Journal of Toxicology, January 1, 2001; 20(2_suppl): 31 - 39. [Abstract] [PDF]

				I. Maidment The use of St John's Wort in the treatment of depression Psychiatr. Bull., June 1, 2000; 24(6): 232 - 234. [Abstract] [Full Text]

				G. Harrer and V. Schulz Clinical Investigation of the Antidepressant Effectiveness of Hypericum J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S6 - S8. [Abstract] [PDF]

				E.-U. Vorbach, W.-D. Hubner, and K.-H. Arnoldt Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 Outpatients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S19 - S23. [Abstract] [PDF]

				G. Harrer, W.-D. Hubner, and H. Podzuweit Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind Study J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S24 - S28. [Abstract] [PDF]

				H. Schulz and M. Jobert Effects of Hypericum Extract on the Sleep EEG in Older Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S39 - S43. [Abstract] [PDF]

				D. Johnson, H. Ksciuk, H. Woelk, E. Sauerwein-Giese, and A. Frauendorf Effects of Hypericum Extract LI 160 Compared with Maprotiline on Resting EEG and Evoked Potentials in 24 Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S44 - S46. [Abstract] [PDF]